Mark Strobeck insider trades: Rockwell Medical (RMTI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | RMTI | ↓ Sell | 1,000 | $8.42 | $8K | Direct | Oct 5, 2026 (4d) |
| Oct 1, 2025 | RMTI | ↓ Sell | 6,926 | $1.19 | $8K | Direct | Oct 1, 2025 (0d) |
| Jul 1, 2025 | RMTI | ↓ Sell | 6,926 | $0.82 | $6K | Direct | Jul 2, 2025 (1d) |
| Apr 1, 2025 | RMTI | ↓ Sell | 6,926 | $1.08 | $7K | Direct | Apr 2, 2025 (1d) |
| Jan 2, 2025 | RMTI | ↓ Sell | 2,163 | $2.06 | $4K | Direct | Jan 6, 2025 (4d) |
| Oct 1, 2024 | RMTI | ↓ Sell | 2,163 | $3.69 | $8K | Direct | Oct 2, 2024 (1d) |
| Oct 2, 2017 | EGLT | ↓ Sell | 8,700 | $1.29 | $11K | Direct | Oct 3, 2017 (1d) |
| Jun 30, 2017 | EGLT | ↓ Sell | 8,700 | $2.39 | $21K | Direct | Jul 5, 2017 (5d) |
| Mar 31, 2017 | EGLT | ↓ Sell | 8,700 | $5.11 | $44K | Direct | Mar 31, 2017 (0d) |
| Dec 30, 2016 | EGLT | ↓ Sell | 8,700 | $7.81 | $68K | Direct | Jan 4, 2017 (5d) |
| Sep 30, 2016 | EGLT | ↓ Sell | 33,700 | $7.58 | $255K | Direct | Oct 3, 2016 (3d) |
| Jun 30, 2016 | EGLT | ↓ Sell | 8,700 | $4.68 | $41K | Direct | Jul 5, 2016 (5d) |
| Mar 31, 2016 | EGLT | ↓ Sell | 8,700 | $6.70 | $58K | Direct | Apr 4, 2016 (4d) |
| Dec 31, 2015 | EGLT | ↓ Sell | 8,700 | $10.40 | $90K | Direct | Jan 5, 2016 (5d) |
| Sep 30, 2015 | EGLT | ↓ Sell | 5,220 | $12.56 | $66K | Direct | Oct 2, 2015 (2d) |
| Jul 1, 2015 | EGLT | ↓ Sell | 10,440 | $12.98 | $136K | Direct | Jul 2, 2015 (1d) |
| Jan 2, 2015 | EGLT | ↓ Sell | 3,480 | $5.09 | $18K | Direct | Jan 5, 2015 (3d) |
| Aug 13, 2014 | EGLT | ↓ Sell | 5,135 | $9.20 | $47K | Direct | Aug 14, 2014 (1d) |
| Aug 11, 2014 | EGLT | ↓ Sell | 5,700 | $10.28 | $59K | Direct | Aug 12, 2014 (1d) |
| Aug 7, 2014 | EGLT | ↓ Sell | 3,085 | $11.50 | $35K | Direct | Aug 8, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RMTI insiders
Open-market trades in the last 12 months
About Mark Strobeck's insider trades
Mark Strobeck is President and CEO at Rockwell Medical (RMTI). Since Aug 7, 2014, Mark has reported no open-market purchases and 20 sales worth $992K on SEC Form 4. In the last 12 months: 1 sale ($8K).
Their filings also include grants and awards (17 filings), shares withheld for taxes (5 filings), shares returned to the company (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.